Please use this identifier to cite or link to this item:
https://doi.org/10.1016/s2666-5247(21)00039-2
| Title: | COVID-19 drug practices risk antimicrobial resistance evolution | Authors: | Afshinnekoo, Ebrahim Bhattacharya, Chandrima Burguete-García, A. Castro-Nallar, Eduardo Deng, Youping Desnues, Christelle Dias-Neto, Emmanuel Elhaik, Eran Iraola, Gregorio Jang, Soojin Łabaj, P.P. Mason, Christopher E. Nagarajan, Niranjan Poulsen, Michael Prithiviraj, Bharath Siam, Rania Shi, Tieliu Suzuki, Haruo Werner, Johannes Mercedes Zambrano, Maria Bhattacharyya, Malay MetaSUB Consortium. |
Issue Date: | 1-Apr-2021 | Publisher: | Elsevier Ltd | Citation: | Afshinnekoo, Ebrahim, Bhattacharya, Chandrima, Burguete-García, A., Castro-Nallar, Eduardo, Deng, Youping, Desnues, Christelle, Dias-Neto, Emmanuel, Elhaik, Eran, Iraola, Gregorio, Jang, Soojin, Łabaj, P.P., Mason, Christopher E., Nagarajan, Niranjan, Poulsen, Michael, Prithiviraj, Bharath, Siam, Rania, Shi, Tieliu, Suzuki, Haruo, Werner, Johannes, Mercedes Zambrano, Maria, Bhattacharyya, Malay, MetaSUB Consortium. (2021-04-01). COVID-19 drug practices risk antimicrobial resistance evolution. The Lancet Microbe 2 (4). ScholarBank@NUS Repository. https://doi.org/10.1016/s2666-5247(21)00039-2 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International | Source Title: | The Lancet Microbe | URI: | https://scholarbank.nus.edu.sg/handle/10635/232495 | ISSN: | 2666-5247 | DOI: | 10.1016/s2666-5247(21)00039-2 | Rights: | Attribution-NonCommercial-NoDerivatives 4.0 International |
| Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| 10_1016_s2666-5247(21)00039-2.pdf | 193.18 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License
